Global Biologics Drug Development Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 278198
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Biologics Drug Development market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Biologics Drug Development market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. In-House accounting for % of the Biologics Drug Development global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Clinical Manufacturing segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Biologics Drug Development include Abbvie, Allergan, Boehringer Ingelheim, Charles River Laboratories, and Catalent, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Biologics Drug Development market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Clinical Manufacturing

Formulation Development

Bioassay Development

Analytical Services

Market segment by Application, can be divided into

In-House

Outsource

Pharma Excess

Market segment by players, this report covers

Abbvie

Allergan

Boehringer Ingelheim

Charles River Laboratories

Catalent

Lonza Group

Amgen

Sanofi

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Biologics Drug Development product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Biologics Drug Development, with revenue, gross margin and global market share of Biologics Drug Development from 2019 to 2022.

Chapter 3, the Biologics Drug Development competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biologics Drug Development market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Biologics Drug Development research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Biologics Drug Development

1.2 Classification of Biologics Drug Development by Type

1.2.1 Overview: Global Biologics Drug Development Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Biologics Drug Development Revenue Market Share by Type in 2021

1.2.3 Clinical Manufacturing

1.2.4 Formulation Development

1.2.5 Bioassay Development

1.2.6 Analytical Services

1.3 Global Biologics Drug Development Market by Application

1.3.1 Overview: Global Biologics Drug Development Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 In-House

1.3.3 Outsource

1.3.4 Pharma Excess

1.4 Global Biologics Drug Development Market Size & Forecast

1.5 Global Biologics Drug Development Market Size and Forecast by Region

1.5.1 Global Biologics Drug Development Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Biologics Drug Development Market Size by Region, (2017-2022)

1.5.3 North America Biologics Drug Development Market Size and Prospect (2017-2028)

1.5.4 Europe Biologics Drug Development Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Biologics Drug Development Market Size and Prospect (2017-2028)

1.5.6 South America Biologics Drug Development Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Biologics Drug Development Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Biologics Drug Development Market Drivers

1.6.2 Biologics Drug Development Market Restraints

1.6.3 Biologics Drug Development Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Abbvie

2.1.1 Abbvie Details

2.1.2 Abbvie Major Business

2.1.3 Abbvie Biologics Drug Development Product and Solutions

2.1.4 Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbvie Recent Developments and Future Plans

2.2 Allergan

2.2.1 Allergan Details

2.2.2 Allergan Major Business

2.2.3 Allergan Biologics Drug Development Product and Solutions

2.2.4 Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Allergan Recent Developments and Future Plans

2.3 Boehringer Ingelheim

2.3.1 Boehringer Ingelheim Details

2.3.2 Boehringer Ingelheim Major Business

2.3.3 Boehringer Ingelheim Biologics Drug Development Product and Solutions

2.3.4 Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Boehringer Ingelheim Recent Developments and Future Plans

2.4 Charles River Laboratories

2.4.1 Charles River Laboratories Details

2.4.2 Charles River Laboratories Major Business

2.4.3 Charles River Laboratories Biologics Drug Development Product and Solutions

2.4.4 Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Charles River Laboratories Recent Developments and Future Plans

2.5 Catalent

2.5.1 Catalent Details

2.5.2 Catalent Major Business

2.5.3 Catalent Biologics Drug Development Product and Solutions

2.5.4 Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Catalent Recent Developments and Future Plans

2.6 Lonza Group

2.6.1 Lonza Group Details

2.6.2 Lonza Group Major Business

2.6.3 Lonza Group Biologics Drug Development Product and Solutions

2.6.4 Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Lonza Group Recent Developments and Future Plans

2.7 Amgen

2.7.1 Amgen Details

2.7.2 Amgen Major Business

2.7.3 Amgen Biologics Drug Development Product and Solutions

2.7.4 Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Amgen Recent Developments and Future Plans

2.8 Sanofi

2.8.1 Sanofi Details

2.8.2 Sanofi Major Business

2.8.3 Sanofi Biologics Drug Development Product and Solutions

2.8.4 Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Sanofi Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Biologics Drug Development Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Biologics Drug Development Players Market Share in 2021

3.2.2 Top 10 Biologics Drug Development Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Biologics Drug Development Players Head Office, Products and Services Provided

3.4 Biologics Drug Development Mergers & Acquisitions

3.5 Biologics Drug Development New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Biologics Drug Development Revenue and Market Share by Type (2017-2022)

4.2 Global Biologics Drug Development Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Biologics Drug Development Revenue Market Share by Application (2017-2022)

5.2 Global Biologics Drug Development Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Biologics Drug Development Revenue by Type (2017-2028)

6.2 North America Biologics Drug Development Revenue by Application (2017-2028)

6.3 North America Biologics Drug Development Market Size by Country

6.3.1 North America Biologics Drug Development Revenue by Country (2017-2028)

6.3.2 United States Biologics Drug Development Market Size and Forecast (2017-2028)

6.3.3 Canada Biologics Drug Development Market Size and Forecast (2017-2028)

6.3.4 Mexico Biologics Drug Development Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Biologics Drug Development Revenue by Type (2017-2028)

7.2 Europe Biologics Drug Development Revenue by Application (2017-2028)

7.3 Europe Biologics Drug Development Market Size by Country

7.3.1 Europe Biologics Drug Development Revenue by Country (2017-2028)

7.3.2 Germany Biologics Drug Development Market Size and Forecast (2017-2028)

7.3.3 France Biologics Drug Development Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Biologics Drug Development Market Size and Forecast (2017-2028)

7.3.5 Russia Biologics Drug Development Market Size and Forecast (2017-2028)

7.3.6 Italy Biologics Drug Development Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Biologics Drug Development Revenue by Type (2017-2028)

8.2 Asia-Pacific Biologics Drug Development Revenue by Application (2017-2028)

8.3 Asia-Pacific Biologics Drug Development Market Size by Region

8.3.1 Asia-Pacific Biologics Drug Development Revenue by Region (2017-2028)

8.3.2 China Biologics Drug Development Market Size and Forecast (2017-2028)

8.3.3 Japan Biologics Drug Development Market Size and Forecast (2017-2028)

8.3.4 South Korea Biologics Drug Development Market Size and Forecast (2017-2028)

8.3.5 India Biologics Drug Development Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Biologics Drug Development Market Size and Forecast (2017-2028)

8.3.7 Australia Biologics Drug Development Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Biologics Drug Development Revenue by Type (2017-2028)

9.2 South America Biologics Drug Development Revenue by Application (2017-2028)

9.3 South America Biologics Drug Development Market Size by Country

9.3.1 South America Biologics Drug Development Revenue by Country (2017-2028)

9.3.2 Brazil Biologics Drug Development Market Size and Forecast (2017-2028)

9.3.3 Argentina Biologics Drug Development Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Biologics Drug Development Revenue by Type (2017-2028)

10.2 Middle East & Africa Biologics Drug Development Revenue by Application (2017-2028)

10.3 Middle East & Africa Biologics Drug Development Market Size by Country

10.3.1 Middle East & Africa Biologics Drug Development Revenue by Country (2017-2028)

10.3.2 Turkey Biologics Drug Development Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Biologics Drug Development Market Size and Forecast (2017-2028)

10.3.4 UAE Biologics Drug Development Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Biologics Drug Development Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Biologics Drug Development Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Biologics Drug Development Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Biologics Drug Development Revenue (USD Million) by Region (2017-2022)

Table 5. Global Biologics Drug Development Revenue Market Share by Region (2023-2028)

Table 6. Abbvie Corporate Information, Head Office, and Major Competitors

Table 7. Abbvie Major Business

Table 8. Abbvie Biologics Drug Development Product and Solutions

Table 9. Abbvie Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Allergan Corporate Information, Head Office, and Major Competitors

Table 11. Allergan Major Business

Table 12. Allergan Biologics Drug Development Product and Solutions

Table 13. Allergan Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 15. Boehringer Ingelheim Major Business

Table 16. Boehringer Ingelheim Biologics Drug Development Product and Solutions

Table 17. Boehringer Ingelheim Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Charles River Laboratories Corporate Information, Head Office, and Major Competitors

Table 19. Charles River Laboratories Major Business

Table 20. Charles River Laboratories Biologics Drug Development Product and Solutions

Table 21. Charles River Laboratories Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Catalent Corporate Information, Head Office, and Major Competitors

Table 23. Catalent Major Business

Table 24. Catalent Biologics Drug Development Product and Solutions

Table 25. Catalent Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Lonza Group Corporate Information, Head Office, and Major Competitors

Table 27. Lonza Group Major Business

Table 28. Lonza Group Biologics Drug Development Product and Solutions

Table 29. Lonza Group Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Amgen Corporate Information, Head Office, and Major Competitors

Table 31. Amgen Major Business

Table 32. Amgen Biologics Drug Development Product and Solutions

Table 33. Amgen Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Sanofi Corporate Information, Head Office, and Major Competitors

Table 35. Sanofi Major Business

Table 36. Sanofi Biologics Drug Development Product and Solutions

Table 37. Sanofi Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Global Biologics Drug Development Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 39. Global Biologics Drug Development Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 40. Breakdown of Biologics Drug Development by Company Type (Tier 1, Tier 2 and Tier 3)

Table 41. Biologics Drug Development Players Head Office, Products and Services Provided

Table 42. Biologics Drug Development Mergers & Acquisitions in the Past Five Years

Table 43. Biologics Drug Development New Entrants and Expansion Plans

Table 44. Global Biologics Drug Development Revenue (USD Million) by Type (2017-2022)

Table 45. Global Biologics Drug Development Revenue Share by Type (2017-2022)

Table 46. Global Biologics Drug Development Revenue Forecast by Type (2023-2028)

Table 47. Global Biologics Drug Development Revenue by Application (2017-2022)

Table 48. Global Biologics Drug Development Revenue Forecast by Application (2023-2028)

Table 49. North America Biologics Drug Development Revenue by Type (2017-2022) & (USD Million)

Table 50. North America Biologics Drug Development Revenue by Type (2023-2028) & (USD Million)

Table 51. North America Biologics Drug Development Revenue by Application (2017-2022) & (USD Million)

Table 52. North America Biologics Drug Development Revenue by Application (2023-2028) & (USD Million)

Table 53. North America Biologics Drug Development Revenue by Country (2017-2022) & (USD Million)

Table 54. North America Biologics Drug Development Revenue by Country (2023-2028) & (USD Million)

Table 55. Europe Biologics Drug Development Revenue by Type (2017-2022) & (USD Million)

Table 56. Europe Biologics Drug Development Revenue by Type (2023-2028) & (USD Million)

Table 57. Europe Biologics Drug Development Revenue by Application (2017-2022) & (USD Million)

Table 58. Europe Biologics Drug Development Revenue by Application (2023-2028) & (USD Million)

Table 59. Europe Biologics Drug Development Revenue by Country (2017-2022) & (USD Million)

Table 60. Europe Biologics Drug Development Revenue by Country (2023-2028) & (USD Million)

Table 61. Asia-Pacific Biologics Drug Development Revenue by Type (2017-2022) & (USD Million)

Table 62. Asia-Pacific Biologics Drug Development Revenue by Type (2023-2028) & (USD Million)

Table 63. Asia-Pacific Biologics Drug Development Revenue by Application (2017-2022) & (USD Million)

Table 64. Asia-Pacific Biologics Drug Development Revenue by Application (2023-2028) & (USD Million)

Table 65. Asia-Pacific Biologics Drug Development Revenue by Region (2017-2022) & (USD Million)

Table 66. Asia-Pacific Biologics Drug Development Revenue by Region (2023-2028) & (USD Million)

Table 67. South America Biologics Drug Development Revenue by Type (2017-2022) & (USD Million)

Table 68. South America Biologics Drug Development Revenue by Type (2023-2028) & (USD Million)

Table 69. South America Biologics Drug Development Revenue by Application (2017-2022) & (USD Million)

Table 70. South America Biologics Drug Development Revenue by Application (2023-2028) & (USD Million)

Table 71. South America Biologics Drug Development Revenue by Country (2017-2022) & (USD Million)

Table 72. South America Biologics Drug Development Revenue by Country (2023-2028) & (USD Million)

Table 73. Middle East & Africa Biologics Drug Development Revenue by Type (2017-2022) & (USD Million)

Table 74. Middle East & Africa Biologics Drug Development Revenue by Type (2023-2028) & (USD Million)

Table 75. Middle East & Africa Biologics Drug Development Revenue by Application (2017-2022) & (USD Million)

Table 76. Middle East & Africa Biologics Drug Development Revenue by Application (2023-2028) & (USD Million)

Table 77. Middle East & Africa Biologics Drug Development Revenue by Country (2017-2022) & (USD Million)

Table 78. Middle East & Africa Biologics Drug Development Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Biologics Drug Development Picture

Figure 2. Global Biologics Drug Development Revenue Market Share by Type in 2021

Figure 3. Clinical Manufacturing

Figure 4. Formulation Development

Figure 5. Bioassay Development

Figure 6. Analytical Services

Figure 7. Biologics Drug Development Revenue Market Share by Application in 2021

Figure 8. In-House Picture

Figure 9. Outsource Picture

Figure 10. Pharma Excess Picture

Figure 11. Global Biologics Drug Development Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Biologics Drug Development Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Biologics Drug Development Revenue Market Share by Region (2017-2028)

Figure 14. Global Biologics Drug Development Revenue Market Share by Region in 2021

Figure 15. North America Biologics Drug Development Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Biologics Drug Development Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Biologics Drug Development Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Biologics Drug Development Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Biologics Drug Development Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Biologics Drug Development Market Drivers

Figure 21. Biologics Drug Development Market Restraints

Figure 22. Biologics Drug Development Market Trends

Figure 23. Abbvie Recent Developments and Future Plans

Figure 24. Allergan Recent Developments and Future Plans

Figure 25. Boehringer Ingelheim Recent Developments and Future Plans

Figure 26. Charles River Laboratories Recent Developments and Future Plans

Figure 27. Catalent Recent Developments and Future Plans

Figure 28. Lonza Group Recent Developments and Future Plans

Figure 29. Amgen Recent Developments and Future Plans

Figure 30. Sanofi Recent Developments and Future Plans

Figure 31. Global Biologics Drug Development Revenue Share by Players in 2021

Figure 32. Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 33. Global Top 3 Players Biologics Drug Development Revenue Market Share in 2021

Figure 34. Global Top 10 Players Biologics Drug Development Revenue Market Share in 2021

Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 36. Global Biologics Drug Development Revenue Share by Type in 2021

Figure 37. Global Biologics Drug Development Market Share Forecast by Type (2023-2028)

Figure 38. Global Biologics Drug Development Revenue Share by Application in 2021

Figure 39. Global Biologics Drug Development Market Share Forecast by Application (2023-2028)

Figure 40. North America Biologics Drug Development Sales Market Share by Type (2017-2028)

Figure 41. North America Biologics Drug Development Sales Market Share by Application (2017-2028)

Figure 42. North America Biologics Drug Development Revenue Market Share by Country (2017-2028)

Figure 43. United States Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Canada Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Mexico Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Europe Biologics Drug Development Sales Market Share by Type (2017-2028)

Figure 47. Europe Biologics Drug Development Sales Market Share by Application (2017-2028)

Figure 48. Europe Biologics Drug Development Revenue Market Share by Country (2017-2028)

Figure 49. Germany Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. France Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. United Kingdom Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Russia Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Italy Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Asia-Pacific Biologics Drug Development Sales Market Share by Type (2017-2028)

Figure 55. Asia-Pacific Biologics Drug Development Sales Market Share by Application (2017-2028)

Figure 56. Asia-Pacific Biologics Drug Development Revenue Market Share by Region (2017-2028)

Figure 57. China Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. South Korea Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Biologics Drug Development Sales Market Share by Type (2017-2028)

Figure 64. South America Biologics Drug Development Sales Market Share by Application (2017-2028)

Figure 65. South America Biologics Drug Development Revenue Market Share by Country (2017-2028)

Figure 66. Brazil Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Argentina Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Middle East and Africa Biologics Drug Development Sales Market Share by Type (2017-2028)

Figure 69. Middle East and Africa Biologics Drug Development Sales Market Share by Application (2017-2028)

Figure 70. Middle East and Africa Biologics Drug Development Revenue Market Share by Country (2017-2028)

Figure 71. Turkey Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. UAE Biologics Drug Development Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Methodology

Figure 75. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz